Levine Zurit 4
4 · COMPUGEN LTD · Filed Apr 9, 2026
Research Summary
AI-generated summary of this filing
Compugen (CGEN) SVP Levine Zurit Exercises Options, Sells Shares
What Happened
Levine Zurit, Senior Vice President, Business Development at Compugen Ltd (CGEN), exercised a total of 7,875 option shares (2,500 on Apr 7; 4,375 and 1,000 on Apr 8) and sold the same 7,875 shares in open-market transactions. Exercise prices were $0.83 (2,500 and 4,375 shares) and $1.15 (1,000 shares); the reported proceeds from the sales were $5,750 (2,500 shares at $2.30) and $13,008 (5,375 shares at $2.42), totaling $18,758. The cash paid to exercise the options (reported amounts) was $6,851. The filing shows corresponding derivative line items at $0.00 for the option-to-share conversions.
Key Details
- Transaction dates/prices:
- 2026-04-07: Exercised 2,500 options @ $0.83 (acquired); sold 2,500 shares @ $2.30 (disposed).
- 2026-04-08: Exercised 4,375 options @ $0.83 and 1,000 options @ $1.15 (acquired); sold 5,375 shares @ $2.42 (disposed).
- Shares exercised (acquired): 7,875. Shares sold (disposed): 7,875. Sale proceeds reported: $18,758. Exercise cash reported: $6,851.
- Shares owned after the transactions: Not specified in this Form 4 filing.
- Footnotes:
- F1: The sales were made pursuant to a Rule 10b5-1 trading plan adopted Dec 23, 2025 (pre-arranged plan).
- F2/F3: The exercised options have vesting schedules (partial vesting in 2023/2024 and remaining vesting quarterly thereafter subject to continued service).
- Filing timeliness: Form filed 2026-04-09 for transactions on Apr 7–8; filing appears timely (no late filing flag).
Context
- This pattern—exercising vested options and immediately selling the resulting shares—is commonly a cashless exercise to cover strike price, taxes, or diversify holdings; the filing shows option-to-share conversions and same-day sales.
- The presence of a 10b5-1 plan means the sales were prearranged and do not necessarily indicate a change in the insider’s view of the company.
- For retail investors: purchases (insider buys) often attract more attention as potential bullish signals; this filing reflects option exercise and sale rather than a straightforward buy.
Insider Transaction Report
- Exercise/Conversion
Ordinary Shares
[F1]2026-04-07$0.83/sh+2,500$2,073→ 31,875 total - Sale
Ordinary Shares
[F1]2026-04-07$2.30/sh−2,500$5,750→ 29,375 total - Exercise/Conversion
Ordinary Shares
[F1]2026-04-08$0.83/sh+4,375$3,628→ 33,750 total - Exercise/Conversion
Ordinary Shares
[F1]2026-04-08$1.15/sh+1,000$1,150→ 34,750 total - Sale
Ordinary Shares
[F1]2026-04-08$2.42/sh−5,375$13,008→ 29,375 total - Exercise/Conversion
Share Option (right to buy)
[F1][F2]2026-04-07−2,500→ 11,125 totalExercise: $0.83Exp: 2032-11-09→ Ordinary Shares (2,500 underlying) - Exercise/Conversion
Share Option (right to buy)
[F1][F2]2026-04-08−4,375→ 6,750 totalExercise: $0.83Exp: 2032-11-09→ Ordinary Shares (4,375 underlying) - Exercise/Conversion
Share Option (right to buy)
[F1][F3]2026-04-08−1,000→ 58,000 totalExercise: $1.15Exp: 2033-08-03→ Ordinary Shares (1,000 underlying)
Footnotes (3)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.
- [F2]This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
- [F3]This option vested 25% on September 30, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.